Detalhe da pesquisa
1.
High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial).
Gastroenterology
; 141(1): 119-27, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21439960
2.
Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France.
Hepatology
; 50(5): 1351-9, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19676130
3.
Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study.
Liver Int
; 30(7): 1049-58, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20492512
4.
Pharmacological exposure to ribavirin: a key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment.
Dig Liver Dis
; 43(11): 850-5, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21596633